Arena Pharmaceuticals Inc sell tinelchen
Summary
This prediction ended on 06.01.22 with a price of €82.50. With a performance of 1.23%, the SELL prediction by tinelchen for Arena Pharmaceuticals Inc was trending in the wrong direction This prediction was marked as speculative and is excluded from tinelchen's performance statistics.Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arena Pharmaceuticals Inc | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% |
According to tinelchen what are the pros and cons of Arena Pharmaceuticals Inc for the foreseeable future?
Pros
Cons
Comments by tinelchen for this prediction
In the thread Arena Pharmaceuticals Inc diskutieren
In the thread Trading Arena Pharmaceuticals Inc